Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Ehsan Mahmoodi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Heart Failure, Death, Sudden, Cardiac. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) has become an established alternative to overcome conventional transvenous ICD (TV‐ICD) lead‐related complications.
Aims
To describe the long‐term outcomes of S‐ICD implantation at a single Australian institution.
Methods
We retrospectively reviewed the clinical outcomes of consecutive patients who underwent S‐ICD implantation from 2015 to 2019.
Results
In total, 128 patients (median age 52.5 years, 70% male) underwent S‐ICD implantation. The indication was primary prevention in 86 patients (66%), and 22 patients (17%) had a previous transvenous device. Seventy‐seven patients (60%) had heart failure, and the median left ventricular ejection fraction was 36% (29%–60%). The procedure was performed under general anaesthesia in 124 patients (97%), and the median procedure time was 105 min (interquartile range (IQR) 90–120). During a median follow‐up of 4.7 years (IQR 3.8–5.8), 15 patients (12%) died, none of which were due to sudden death or device‐related complications. Inappropriate shocks occurred in 17 patients (13.3%), predominantly due to T‐wave oversensing (4.7%) and supraventricular arrhythmias (4.7%), and 15 patients (11.7%) received appropriate shocks. During the follow‐up period, the S‐ICD system was revised to TV‐ICD in 10 patients (8%), and 24 patients (19%) required S‐ICD generator change. Four patients (3%) underwent surgical intervention due to lead (two) or pocket‐related (two) complications, and two patients (1.5%) developed pocket infection without systemic sepsis.
Conclusion
In this single‐centre study, S‐ICDs were implanted safely with acceptable device performance and clinical outcomes over long‐term follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland, Australia.
- Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
ORCID-Profile: Ehsan Mahmoodi
Zitieren
APA
Mahmoodi, E., Lee, X. W., Freeman, B. M., Webster, M. A., Betts, J. R., Haqqani, H. M., & Denman, R. A. (2025). Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience. Internal Medicine Journal. https://doi.org/10.1111/imj.70014
Vancouver
Mahmoodi E, Lee XW, Freeman BM, Webster MA, Betts JR, Haqqani HM, et al. Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience. Internal Medicine Journal. 2025. doi:10.1111/imj.70014
BibTeX
@article{Mahmoodi2025,
author = {Mahmoodi, Ehsan and Lee, Xiang Wen and Freeman, Blake M and Webster, Meghan A and Betts, John R and Haqqani, Haris M and Denman, Russell A},
title = {Long‐term outcomes of subcutaneous implantable cardioverter‐defibrillators: a single‐centre Australian experience},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70014}
}
EUVIMED